Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,479 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma.
von Figura G, Fukuda A, Roy N, Liku ME, Morris Iv JP, Kim GE, Russ HA, Firpo MA, Mulvihill SJ, Dawson DW, Ferrer J, Mueller WF, Busch A, Hertel KJ, Hebrok M. von Figura G, et al. Among authors: ferrer j. Nat Cell Biol. 2014 Mar;16(3):255-67. doi: 10.1038/ncb2916. Epub 2014 Feb 23. Nat Cell Biol. 2014. PMID: 24561622 Free PMC article.
Concurrent Activation of Kras and Canonical Wnt Signaling Induces Premalignant Lesions That Progress to Extrahepatic Biliary Cancer in Mice.
Nagao M, Fukuda A, Omatsu M, Namikawa M, Sono M, Fukunaga Y, Masuda T, Araki O, Yoshikawa T, Ogawa S, Masuo K, Goto N, Hiramatsu Y, Muta Y, Tsuda M, Maruno T, Nakanishi Y, Taketo MM, Ferrer J, Tsuruyama T, Nakanuma Y, Taura K, Uemoto S, Seno H. Nagao M, et al. Among authors: ferrer j. Cancer Res. 2022 May 3;82(9):1803-1817. doi: 10.1158/0008-5472.CAN-21-2176. Cancer Res. 2022. PMID: 35247892
Loss of Arid1a and Pten in Pancreatic Ductal Cells Induces Intraductal Tubulopapillary Neoplasm via the YAP/TAZ Pathway.
Fukunaga Y, Fukuda A, Omatsu M, Namikawa M, Sono M, Masuda T, Araki O, Nagao M, Yoshikawa T, Ogawa S, Hiramatsu Y, Muta Y, Tsuda M, Maruno T, Nakanishi Y, Ferrer J, Tsuruyama T, Masui T, Hatano E, Seno H. Fukunaga Y, et al. Among authors: ferrer j. Gastroenterology. 2022 Aug;163(2):466-480.e6. doi: 10.1053/j.gastro.2022.04.020. Epub 2022 Apr 25. Gastroenterology. 2022. PMID: 35483445
Current challenges in understanding the role of enhancers in disease.
Zaugg JB, Sahlén P, Andersson R, Alberich-Jorda M, de Laat W, Deplancke B, Ferrer J, Mandrup S, Natoli G, Plewczynski D, Rada-Iglesias A, Spicuglia S. Zaugg JB, et al. Among authors: ferrer j. Nat Struct Mol Biol. 2022 Dec;29(12):1148-1158. doi: 10.1038/s41594-022-00896-3. Epub 2022 Dec 8. Nat Struct Mol Biol. 2022. PMID: 36482255 Review.
Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery.
Buniello A, Suveges D, Cruz-Castillo C, Llinares MB, Cornu H, Lopez I, Tsukanov K, Roldán-Romero JM, Mehta C, Fumis L, McNeill G, Hayhurst JD, Martinez Osorio RE, Barkhordari E, Ferrer J, Carmona M, Uniyal P, Falaguera MJ, Rusina P, Smit I, Schwartzentruber J, Alegbe T, Ho VW, Considine D, Ge X, Szyszkowski S, Tsepilov Y, Ghoussaini M, Dunham I, Hulcoop DG, McDonagh EM, Ochoa D. Buniello A, et al. Among authors: ferrer j. Nucleic Acids Res. 2024 Dec 6:gkae1128. doi: 10.1093/nar/gkae1128. Online ahead of print. Nucleic Acids Res. 2024. PMID: 39657122
Cholangiocarcinoma in Latin America: a multicentre observational study alerts on ethnic disparities in tumour presentation and outcomes.
da Fonseca LG, Izquierdo-Sanchez L, Hashizume PH, Carlino Y, Baca EL, Zambrano C, Sepúlveda SA, Bolomo A, Rodrigues PM, Riaño I, Boonstra A, Debes JD, Bujanda L, Carrilho FJ, Arrese M, Roa JC, Carrera E, Ferrer JD, Balderramo D, Oliveira CP, Banales JM. da Fonseca LG, et al. Among authors: ferrer jd. Lancet Reg Health Am. 2024 Nov 25;40:100952. doi: 10.1016/j.lana.2024.100952. eCollection 2024 Dec. Lancet Reg Health Am. 2024. PMID: 39655285 Free PMC article.
PERSISTENCE, EFFECTIVENESS, AND SAFETY OF UPADACITINIB IN CROHN'S DISEASE AND ULCERATIVE COLITIS IN REAL LIFE: RESULTS FROM A SPANISH NATIONWIDE STUDY (UREAL STUDY): Upadacitinib for IBD.
García MJ, Brenes Y, Vicuña M, Bermejo F, Sierra-Ausín M, Vicente R, Arroyo MT, Montiel PM, Villoria A, Ferrer JÁ, Hernandez V, Piñero A, Carrillo-Palau M, Martín-Arranz MD, Miranda-Bautista J, Pajares R, Hernández LA, Bejarano A, Guardiola J, Iyo E, Muñoz-Villafranca C, Talavera A, Alonso-Galán H, Acosta MB, Bosca-Watts M, Rey TV, Echarri A, Rodríguez-Grau MDC, Gutiérrez A, Huguet JM, López-Martín MC, Mesonero F, Pérez-Martínez I, Plaza R, Ramírez de la Piscina P, Gisbert JP, Chaparro M. García MJ, et al. Among authors: ferrer ja. Am J Gastroenterol. 2024 Nov 26. doi: 10.14309/ajg.0000000000003243. Online ahead of print. Am J Gastroenterol. 2024. PMID: 39588977
1,479 results